Current Report Filing (8-k)
June 12 2019 - 7:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 12, 2019
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37550
|
|
47-4725208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(IRS Employer
Identification No.)
|
|
1573 Mallory Lane
Brentwood, Tennessee 37027
(Address of principal executive offices) (Zip Code)
Registrants Telephone Number, Including Area Code: (615)
221-1400
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $0.0001 par value per share
|
|
QHC
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.05
|
Costs Associated with Exit or Disposal Activities
|
The information set forth in Item 8.01 below is incorporated herein by reference.
Item 7.01
|
Regulation FD Disclosure
|
On June 12, 2019, Quorum Health Corporation (the Company) issued a press release related to the matters discussed below. A
copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
On June 12, 2019, the Company announced that MetroSouth Medical Center in Blue Island, Illinois filed an application with the Illinois
Health Facilities and Service Review Board to discontinue hospital operations. The hospital continues to search for a new operator to offer health care services on the campus. If the Company is not able to divest the facility, it will discontinue
all operations by the end of the fourth quarter of 2019. The Companys decision to discontinue operations at the facility is a result of mounting financial losses due to decreasing patient volumes, increasing market saturation, and reduced
reimbursement from government and commercial payors. The Company has preliminarily begun the process of estimating the costs to be incurred as a result of the closure, but is unable at this time to make a good faith estimate of the major types of
costs or amount or range of amounts that may be incurred in connection with this closure, or an estimate of the amount or range of amounts of any charges that would result in future cash expenditures, including whether any such charges will be
material. As these amounts are still being finalized, if the charges are determined to be material, additional details will be provided in an amendment to this
Form 8-K or
in another of the
Companys filings with the Securities and Exchange Commission.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
QUORUM HEALTH CORPORATION
(registrant)
|
|
|
By:
|
|
/s/ Alfred Lumsdaine
|
|
|
Alfred Lumsdaine
|
|
|
Executive Vice President
|
|
|
and Chief Financial Officer
(principal
financial officer)
|
Date: June 12, 2019
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Sep 2023 to Sep 2024